Page 32 - Read Online

Page 8 of 8 De Luca et al. Mini-invasive Surg 2022;6:13 https://dx.doi.org/10.20517/2574-1225.2021.127

Copyright
© The Author(s) 2022.

REFERENCES
1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in
GLOBOCAN 2012. Int J Cancer 2015;136:E359-86. DOI PubMed
2. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical
presentation and primary management. J Clin Oncol 2004;22:2141-9. DOI PubMed PMC
3. Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1:
screening, diagnosis, and local treatment with curative intent. Eur Urol 2021;79:243-62. DOI PubMed
4. Schröder FH, Hugosson J, Roobol MJ, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European
study. N Engl J Med 2009;360:1320-8. DOI PubMed
5. De Luca S, Fiori C, Bollito E, et al. Risk of Gleason score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly
reduced by targeted versus standard biopsy. Minerva Urol Nefrol 2020;72:360-8. DOI PubMed
6. Bianchi L, Gandaglia G, Fossati N, et al. Oncologic outcomes in prostate cancer patients treated with robot-assisted radical
prostatectomy: results from a single institution series with more than 10 years follow up. Minerva Urol Nefrol 2019;71:38-46. DOI
PubMed
7. Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA. Contemporary treatments in prostate cancer focal therapy. Curr Opin Oncol
2019;31:200-6. DOI PubMed PMC
8. Valerio M, Cerantola Y, Eggener SE, et al. New and established technology in focal ablation of the prostate: a systematic review. Eur
Urol 2017;71:17-34. DOI PubMed
9. Elkhoury FF, Simopoulos DN, Marks LS. MR-guided biopsy and focal therapy: new options for prostate cancer management. Curr
Opin Urol 2018;28:93-101. DOI PubMed PMC
10. De Luca S, Fiori C, Tucci M, et al. Prostate cancer management at an Italian tertiary referral center: does multidisciplinary team
meeting influence diagnostic and therapeutic decision-making process? Minerva Urol Nefrol 2019;71:576-82. DOI PubMed
11. Guillaumier S, Peters M, Arya M, et al. A multicentre study of 5-year outcomes following focal therapy in treating clinically
significant nonmetastatic prostate cancer. Eur Urol 2018;74:422-9. DOI PubMed PMC
12. Stabile A, Orczyk C, Hosking-Jervis F, et al. Medium-term oncological outcomes in a large cohort of men treated with either focal or
hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer. BJU Int 2019;124:431-40. DOI
PubMed
13. Clery R, Grande P, Seisen T, et al. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent
localized prostate cancer: results from a multicenter study. World J Urol 2019;37:1491-8. DOI PubMed
14. Thompson JE, Sridhar AN, Shaw G, et al. Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical
prostatectomy after high-intensity focused ultrasound partial ablation. BMC Urol 2020;20:81. DOI PubMed PMC
15. Linares Espinós E, Sánchez-Salas R, Sivaraman A, et al. Minimally invasive salvage prostatectomy after primary radiation or ablation
treatment. Urology 2016;94:111-6. DOI PubMed
16. Panebianco V, Villeirs G, Weinreb JC, et al. Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international
consensus-based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and
radical prostatectomy. Eur Urol Oncol 2021;4:868-76. DOI PubMed
17. Roach M 3rd, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in
men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat
Oncol Biol Phys 2006;65:965-74. DOI PubMed
18. Porpiglia F, Bertolo R, Manfredi M, et al. Total anatomical reconstruction during robot-assisted radical prostatectomy: implications on
early recovery of urinary continence. Eur Urol 2016;69:485-95. DOI PubMed
19. Manfredi M, Checcucci E, Fiori C, et al. Total anatomical reconstruction during robot-assisted radical prostatectomy: focus on urinary
continence recovery and related complications after 1000 procedures. BJU Int 2019;124:477-86. DOI PubMed
20. Campobasso D, Fiori C, Amparore D, et al. Total anatomical reconstruction during robot-assisted radical prostatectomy in patients
with previous prostate surgery. Minerva Urol Nefrol 2019;71:605-11. DOI PubMed
21. Montorsi F, Wilson TG, Rosen RC, et al; Pasadena Consensus Panel. Best practices in robot-assisted radical prostatectomy:
recommendations of the Pasadena Consensus Panel. Eur Urol 2012;62:368-81. DOI PubMed
22. Marconi L, Stonier T, Tourinho-Barbosa R, et al. Robot-assisted radical prostatectomy after focal therapy: oncological, functional
outcomes and predictors of recurrence. Eur Urol 2019;76:27-30. DOI PubMed
23. Nunes-Silva I, Barret E, Srougi V, et al. Effect of prior focal therapy on perioperative, oncologic and functional outcomes of salvage
robotic assisted radical prostatectomy. J Urol 2017;198:1069-76. DOI PubMed
24. Checcucci E, Amparore D, De Luca S, Autorino R, Fiori C, Porpiglia F. Precision prostate cancer surgery: an overview of new
technologies and techniques. Minerva Urol Nefrol 2019;71:487-501. DOI PubMed